News

Filter

Current filters:

DepomedGlumetza

Santarus and Depomed expand US deal on Glumetza

23-08-2011

US drugmakers Santarus (Nasdaq: SNTS) and Depomed (Nasdaq: DEPO) have entered into a new commercialization…

DepomedDiabetesGlumetzaLicensingNorth AmericaPharmaceuticalSantarus

Depomed regains rights to Gralise from Abbott; licenses Acuform to Boehringer Ingelheim

18-03-2011

Following a period of mediation, USA-based Depomed (Nasdaq: DEPO) will regain rights to its shingles…

Abbott LaboratoriesAnti-viralsBoehringer IngelheimDepomedDiabetesFinancialGlumetzaGraliseLicensingPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top